Thursday, September 27, 2007

Feedback | Helpdesk | Login

 EDITORIAL
NIMESULIDE UNDER SCAN
past editorials ...
SERVICES
Tenders&Enquiries
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Import Reg. Update
Notified Prices
Company Profiles
Pharmabiz Studies of Top Companies
Corporate Results
Corporate X-ray
Pharma Projects
Indian Cos Approved by Intl Regulatory Agencies
Drug Units With WHO GMP Certification
Drug Export Procedures
Drug Registration Norms for Various Countries
Pharma Export Data
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of banned FDCs w.e.f. 01.01.2002
List of formulations containing PPA
List of FDCs of Rifampicin + Isoniazid
List of Indian CROs
List of CROs (International)
US FDA: Warnings
US FDA: Approved NMEs upto November 2006
US FDA: New Approvals
US approved Labs with Stem Cell Lines
Govt & approved labs of India
Archives: News & Features

Features

 INTERVIEW
"Strategic partnerships will boost drug discovery activities in India"
CSN Murthy is chief executive officer, Dr Reddy's

past interviews ...


NPPA Notification dated September 24, 2007 revising/ fixing prices of 2 non-scheduled formulation pack - NEW
USFDA - Nanotechnology Task Force Report July 25, 2007
New Drug Approvals Updated upto June 2007
US FDA New Approvals Updated Upto July 2007
PHARMA Patent APPLICATIONS PUBLISHED IN INDIA
  Pharmabiz e-Pharmail News

FORTHCOMING EVENTS
International
Domestic

CHRONICLE PHARMABIZ SPECIALS
Forthcoming
Past



CORPORATE
Pharma Stocks
Executive Diary
Pharma People
Product Launches

PHARMA MART
Buyer's Postings
Flash Sales Offer
Used Equipment
Contract Manufacturing
Surplus Inventory



 

Home | Archives | Advertise | Contact Us | About Us | Feedback | Helpdesk | Disclaimer
Copyright © Saffron Media Pvt. Ltd.